C-cbl and antagonists thereof for the treatment and diagnosis of cancer
Номер патента: EP2396407A1
Опубликовано: 21-12-2011
Автор(ы): Daniel Regnier, Eric Tabone, Sadok Yakoub, Serge Manie
Принадлежит: CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, Universite Claude Bernard Lyon 1 UCBL
Опубликовано: 21-12-2011
Автор(ы): Daniel Regnier, Eric Tabone, Sadok Yakoub, Serge Manie
Принадлежит: CENTRE LEON BERARD, CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE CNRS, Universite Claude Bernard Lyon 1 UCBL
Реферат: The present invention relates to the treatment of cancer. More specifically, the present invention relates to the use of c-cbl as a marker for the diagnosis and/or prognosis of cancer, and to the use of a c-cbl antagonist for the treatment of a cancer associated with resistance to apoptosis.
C-cbl and antagonists thereof for the treatment and diagnosis of cancer
Номер патента: CA2751977A1. Автор: Daniel Regnier,Serge Manie,Sadok Yakoub,Eric Tabone. Владелец: Universite Claude Bernard Lyon 1 UCBL. Дата публикации: 2010-08-19.